Formulation and Scale-up of Delamanid Nanoparticles via Emulsification for Oral Tuberculosis Treatment.

Caggiano NJ, Armstrong MS, Georgiou JS, Rawal A, Wilson BK, White CE, Priestley RD, Prud'homme RK

DOI: 10.1021/acs.molpharmaceut.3c00240
Published: 2023 Sep 4
Container: Molecular pharmaceutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.3c00240,
  title = {Formulation and Scale-up of Delamanid Nanoparticles via Emulsification for Oral Tuberculosis Treatment.},
  author = {Caggiano NJ and Armstrong MS and Georgiou JS and Rawal A and Wilson BK and White CE and Priestley RD and Prud'homme RK},
  year = {2023},
  journal = {Molecular pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.3c00240},
  url = {https://doi.org/10.1021/acs.molpharmaceut.3c00240}
}

RIS

TY  - JOUR
TI  - Formulation and Scale-up of Delamanid Nanoparticles via Emulsification for Oral Tuberculosis Treatment.
AU  - Caggiano NJ
AU  - Armstrong MS
AU  - Georgiou JS
AU  - Rawal A
AU  - Wilson BK
AU  - White CE
AU  - Priestley RD
AU  - Prud'homme RK
PY  - 2023
JO  - Molecular pharmaceutics
DO  - 10.1021/acs.molpharmaceut.3c00240
UR  - https://doi.org/10.1021/acs.molpharmaceut.3c00240
ER  -

APA

NJ, C., MS, A., JS, G., A, R., BK, W., CE, W., RD, P., & RK, P. (2023). Formulation and Scale-up of Delamanid Nanoparticles via Emulsification for Oral Tuberculosis Treatment.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00240

Source records

pubmed · retrieved 2026-09-25T23:56:45.130Z